0001655687-21-000004.txt : 20211102 0001655687-21-000004.hdr.sgml : 20211102 20211102153644 ACCESSION NUMBER: 0001655687-21-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211102 DATE AS OF CHANGE: 20211102 EFFECTIVENESS DATE: 20211102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bardavon Health Innovations, Inc. CENTRAL INDEX KEY: 0001655687 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-419529 FILM NUMBER: 211370891 BUSINESS ADDRESS: STREET 1: 6701 W. 64TH STREET STREET 2: BUILDING 5, SUITE 125 CITY: OVERLAND PARK STATE: KS ZIP: 66202 BUSINESS PHONE: 913-236-1020 MAIL ADDRESS: STREET 1: 6701 W. 64TH STREET STREET 2: BUILDING 5, SUITE 125 CITY: OVERLAND PARK STATE: KS ZIP: 66202 FORMER COMPANY: FORMER CONFORMED NAME: Bardavon Health Innovations, LLC DATE OF NAME CHANGE: 20151015 D 1 primary_doc.xml X0708 D LIVE 0001655687 Bardavon Health Innovations, Inc. 6803 W. 64th Street, Bldg 6, Ste 200 Overland Park KS KANSAS 66202 913-236-1020 DELAWARE Bardavon Health Innovations, LLC Corporation true Matthew J Condon 6803 W. 64th Street, Bldg 6, Ste 200 Overland Park KS KANSAS 66202 Executive Officer Director Paul K Morris 6803 W. 64th Street, Bldg 6, Ste 200 Overland Park KS KANSAS 66202 Executive Officer Director Matt Ferguson 6803 W. 64th Street, Bldg 6, Ste 200 Overland Park KS KANSAS 66202 Director Clete T Brewer 6803 W. 64th Street, Bldg 6, Ste 200 Overland Park KS KANSAS 66202 Director Zane Burke 6803 W. 64th Street, Bldg 6, Ste 200 Overland Park KS KANSAS 66202 Director Ed Enyeart 6803 W. 64th Street, Bldg 6, Ste 200 Overland Park KS KANSAS 66202 Executive Officer Karan Takhar 6803 W. 64th Street, Bldg 6, Ste 200 Overland Park KS KANSAS 66202 Director Daphne Tong 6803 W. 64th Street, Bldg 6, Ste 200 Overland Park KS KANSAS 66202 Director Other Technology Decline to Disclose 06b false 2021-10-20 false true false 0 106695156 106695156 0 The total offering amount and total amount sold include $16,695,179 in the conversion of existing promissory notes and $89,999,977 in new cash investments. false 25 0 0 0 false Bardavon Health Innovations, Inc. Ed Enyeart Ed Enyeart CFO 2021-11-02